Glucose–insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

MK Wu, CY Huang, YJ Liou, CK Wang… - International Journal of …, 2008 - nature.com
Objective: Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …
被引用次数：34 相关文章

Glucose–insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.

MK Wu, CY Huang, YJ Liou… - … Journal of Obesity, 2008 - search.ebscohost.com
Objective: Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …
[PDF] academia.edu

[PDF][PDF] Glucose–insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

MK Wu, CY Huang, YJ Liou, CK Wang… - International Journal of …, 2008 - academia.edu
Objective: Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …

Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

MK Wu, CY Huang, YJ Liou, CK Wang… - International Journal of …, 2008 - go.gale.com
Objective: Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …

Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.

MK Wu, CY Huang, YJ Liou, CK Wang, SD Lee - 2008 - cabidigitallibrary.org
Objective: Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …

Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

MK Wu, CY Huang, YJ Liou… - … journal of obesity …, 2008 - pubmed.ncbi.nlm.nih.gov
Objective Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …

Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.

MK Wu, CY Huang, YJ Liou, CK Wang… - International Journal of …, 2007 - europepmc.org
Objective Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …
[PDF] researchgate.net

[PDF][PDF] Glucose–insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

MK Wu, CY Huang, YJ Liou, CK Wang… - International Journal of …, 2008 - researchgate.net
Objective: Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …

[引用][C] Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

MK WU, CY HUANG, YJ LIOU… - … journal of obesity, 2008 - Nature Publishing Group

[引用][C] Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

MK Wu, CY Huang, YJ Liou, CK Wang, SD Lee - 2008